Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.48 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.48 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.45 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 4/20 | 0.39 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4641810 | 0.81 | SLC22A12 (0.54) | TNIKSLC22A12PARP14NR3C1CA1 | |
| SCHEMBL6389949 | 0.81 | SLC22A12 (0.47) | TNIKSLC22A12PARP14NR3C1CA1 | |
| SCHEMBL2005491 | 0.81 | SLC22A12 (0.47) | SLC22A12PARP14NR3C1PGR | |
| SCHEMBL21865747 | 0.80 | RXFP1 (0.55) | SLC22A12RXFP1CRBNPGRMAPT | |
| SCHEMBL9340013 | 0.79 | PARP14 (0.48) | TNIKSLC22A12PARP14NR3C1KEAP1 | |
| SCHEMBL12060800 | 0.79 | SLC22A12 (0.45) | TNIKSLC22A12PARP14NR3C1CA1 | |
| SCHEMBL9340017 | 0.78 | ADRA2A (0.51) | SLC22A12PARP14NR3C1CA1CA2 | |
| SCHEMBL29467983 | 0.78 | ACLY (0.52) | SLC22A12PARP14NR3C1CA1CA2 | |
| SCHEMBL897113 | 0.78 | PARP14 (0.47) | TNIKSLC22A12PARP14NR3C1CA1 | |
| SCHEMBL10208423 | 0.78 | ACLY (0.52) | SLC22A12PARP14NR3C1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080227995-A1 | Process of Sulfonating 4-Aminobenzonitriles | SCHWARZ PHARMA AG (DE) | 2008-09-18 | — | — | US | disclosed |
| US-20080227995-A1 | Process of Sulfonating 4-Aminobenzonitriles | SCHWARZ PHARMA AG (DE) | 2008-09-18 | — | — | US | disclosed |
| US-20080227995-A1 | Process of Sulfonating 4-Aminobenzonitriles | SCHWARZ PHARMA AG (DE) | 2008-09-18 | — | — | US | disclosed |
| EP-1910280-A2 | PROCESS OF SULFONATING 4-AMINOBENZONITRILES | SCHWARZ PHARMA AG (DE) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007009798-A2 | PROCESS OF SULFONATING 4-AMINOBENZONITRILES | SCHWARZ PHARMA AG (DE) | 2007-01-25 | — | — | WO | disclosed |
| WO-2007009798-A2 | PROCESS OF SULFONATING 4-AMINOBENZONITRILES | SCHWARZ PHARMA AG (DE) | 2007-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227995-A1 | Process of Sulfonating 4-Aminobenzonitriles | STS, ARSA, CYP2S1 | TNIK 2878/4885SLC22A12 2305/4885PARP14 2413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.